Weight-loss jabs could slash the risk of becoming addicted to alcohol, cigarettes and drugs by up to a quarter, a major study reveals. Weight-loss drugs include glucagon-like peptide-1 receptor agonists (GLP-1s), which help people feel fuller by mimicking the natural hormone released after eating. Now, a large US study has found the jabs could work to prevent and treat addiction to a range of substances including alcohol, cannabis, cocaine, nicotine and opioids. A large study has found weight loss jabs could work to prevent and treat addiction to a range of substances including alcohol, cannabis, cocaine, nicotine and opioids. Among those with an existing substance use disorder, starting a GLP-1 was linked to 31 per cent lower risk of SUD-related emergency department visits, 26 per cent lower hospital admissions, 50 per cent lower deaths and 39 per cent fewer overdoses alongside 25 per cent lower risk of suicidal thoughts or attempted suicides.

Source: Daily Mail March 04, 2026 23:36 UTC